Back to Journals » Journal of Hepatocellular Carcinoma » The Emerging Multiple Modality Treatment Based on Systemic Therapy for Hepatocellular Carcinoma (HCC)
Journal of Hepatocellular Carcinoma
ISSN: 2253-5969
- View all (573)
- Volume 11, 2024 (49)
- Volume 10, 2023 (176)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Journal Articles:
- Insights and Innovations in Imaging for Hepatocellular Carcinoma: Advancing Diagnosis and Management (3)
- Advanced Radiation Therapy and Radiobiology for Hepatocellular Carcinoma (4)
- The Emerging Multiple Modality Treatment Based on Systemic Therapy for Hepatocellular Carcinoma (HCC) (11)
- Combination of Immune Checkpoint Inhibitors and Locoregional Therapy of Hepatocellular Carcinoma: Hype or Hope (1)
The Emerging Multiple Modality Treatment Based on Systemic Therapy for Hepatocellular Carcinoma (HCC)
Thanks to the rapid development of systemic therapy for HCC in the past 4 years, multi-modality treatments of systemic therapy combined with such aspects as surgery, TACE, transplantation, as well as related prognostic biomarkers, have become current hotspots. This Article Collection collects valuable evidence with various perspectives to provide reference for questions frequently discussed in the clinical practice of HCC treatment.
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy
Li W, Zheng Z, Wang J, Wu T, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z
Journal of Hepatocellular Carcinoma 2024, 11:463-475
Published Date: 4 March 2024
Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma
Liu B, Gao S, Guo J, Kou F, Liu S, Zhang X, Feng A, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Xu L, Zhu X
Journal of Hepatocellular Carcinoma 2024, 11:477-488
Published Date: 4 March 2024
Simultaneous and Sequential Use of Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Real-World Practice in China
Li J, Huang L, Ge C, Zhu X, Qiu M, Chen C, Wei S, Yan Y
Journal of Hepatocellular Carcinoma 2023, 10:949-958
Published Date: 20 June 2023
Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe
Liu J, Sun M, Fang K, Wang J, Ma B, Song L, Liu T, Tang M, Wang K, Xia Y
Journal of Hepatocellular Carcinoma 2023, 10:997-1007
Published Date: 28 June 2023
Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis
Ouyang J, Wang Z, Yuan K, Yang Y, Zhou Y, Li Q, Yang N, Zhao H, Zhao H, Zhou J
Journal of Hepatocellular Carcinoma 2023, 10:1465-1477
Published Date: 6 September 2023
Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study
Chang X, Wu H, Ning S, Li X, Xie Y, Shao W, Yu J
Journal of Hepatocellular Carcinoma 2023, 10:1497-1509
Published Date: 6 September 2023
The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
Hsu HM, Tsai HI, Lee WC, Wang CC, Yu MC, Lin SM, Lin CY, Wu CH, Lee CW
Journal of Hepatocellular Carcinoma 2023, 10:1873-1880
Published Date: 24 October 2023
Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre
Li G, Zhao Y, Li K, Yang S, Xiang C, Song J, Yang Y, Li G, Dong J
Journal of Hepatocellular Carcinoma 2023, 10:2037-2048
Published Date: 9 November 2023
Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy
Zheng Z, Wang J, Wu T, He M, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z
Journal of Hepatocellular Carcinoma 2023, 10:2117-2132
Published Date: 30 November 2023
Predicting T Cell-Inflamed Gene Expression Profile in Hepatocellular Carcinoma Based on Dynamic Contrast-Enhanced Ultrasound Radiomics
Wang Y, Weng W, Liang R, Zhou Q, Hu H, Li M, Chen L, Chen S, Peng S, Kuang M, Xiao H, Wang W
Journal of Hepatocellular Carcinoma 2023, 10:2291-2303
Published Date: 18 December 2023
An Overview of Traditional Chinese Medicine in the Treatment After Radical Resection of Hepatocellular Carcinoma
Peng Y, Wu X, Zhang Y, Yin Y, Chen X, Zheng D, Wang J
Journal of Hepatocellular Carcinoma 2023, 10:2305-2321
Published Date: 18 December 2023